These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 10961040)

  • 1. A review of the United Kingdom Prospective Diabetes Study (UKPDS) and a discussion of the implications for patient care.
    Srimanunthiphol J; Beddow R; Arakaki R
    Hawaii Med J; 2000 Jul; 59(7):295-8, 313. PubMed ID: 10961040
    [No Abstract]   [Full Text] [Related]  

  • 2. United Kingdom prospective diabetes study results are in.
    Genuth S
    J Fam Pract; 1998 Nov; 47(5 Suppl):S27. PubMed ID: 9834752
    [No Abstract]   [Full Text] [Related]  

  • 3. Implications of the United Kingdom prospective diabetes study.
    Baldeweg SE; Yudkin JS
    Prim Care; 1999 Dec; 26(4):809-27. PubMed ID: 10523461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Implications of the United Kingdom Prospective Diabetes Study (UKPDS) results on patient management.
    Nicollerat JA
    Diabetes Educ; 2000; 26 Suppl():8-10. PubMed ID: 11912816
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beyond the UKPDS: in search of the optimal strategy for the treatment of type 2 diabetes.
    Riccardi G
    Nutr Metab Cardiovasc Dis; 2000 Jun; 10(3):104-7. PubMed ID: 11006917
    [No Abstract]   [Full Text] [Related]  

  • 6. [The effect of metformin on late diabetic complications and cardiovascular events in obese patients with type 2 diabetes].
    Christiansen AL; Madsbad S
    Ugeskr Laeger; 2002 Apr; 164(15):2022-4. PubMed ID: 11984999
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduction of body iron stores and the prevention of type 2 diabetes.
    Mascitelli L; Pezzetta F
    Am J Med; 2007 Jan; 120(1):e13; author reply e15. PubMed ID: 17208061
    [No Abstract]   [Full Text] [Related]  

  • 8. Beneficial effects of combined treatment with rosiglitazone and exercise on cardiovascular risk factors in patients with type 2 diabetes.
    Kadoglou NP; Iliadis F; Liapis CD; Perrea D; Angelopoulou N; Alevizos M
    Diabetes Care; 2007 Sep; 30(9):2242-4. PubMed ID: 17586747
    [No Abstract]   [Full Text] [Related]  

  • 9. Implications of the United Kingdom prospective diabetes study for patients with obesity and type 2 diabetes.
    Genuth S
    Obes Res; 2000 Mar; 8(2):198-201. PubMed ID: 10757207
    [No Abstract]   [Full Text] [Related]  

  • 10. Re-thinking metabolic strategies for older people with type 2 diabetes mellitus: implications of the UK Prospective Diabetes Study and other recent studies.
    Sinclair AJ; Meneilly GS
    Age Ageing; 2000 Sep; 29(5):393-7. PubMed ID: 11108410
    [No Abstract]   [Full Text] [Related]  

  • 11. Optimal diabetes management during medical weight loss for cardiovascular risk reduction.
    Nori Janosz KE; Miller WM; Odom J; Lillystone M; McCullough PA
    Expert Rev Cardiovasc Ther; 2005 Jul; 3(4):761-75. PubMed ID: 16076284
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The UKPDS study on glycemic control and arterial hypertension in type II diabetes: objectives, structure and preliminary results].
    Levy JC; Cull CA; Stratton IM; Holman RR; Turner RC
    Journ Annu Diabetol Hotel Dieu; 1993; ():123-37. PubMed ID: 8331860
    [No Abstract]   [Full Text] [Related]  

  • 13. Treating type 2 diabetes--today's targets, tomorrow's goals.
    Alberti KG
    Diabetes Obes Metab; 2001 Aug; 3 Suppl 1():S3-10. PubMed ID: 11685827
    [No Abstract]   [Full Text] [Related]  

  • 14. A primary care register for impaired glucose handling (IGH): impact on cardiometabolic profile.
    Heald AH; Knapman H; Nair S; Chambers T; Radford D; Rushton T; Anderson SG
    Prim Care Diabetes; 2012 Oct; 6(3):213-9. PubMed ID: 22560663
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of type 2 diabetes: one extreme to another.
    Zaidi S
    Arch Intern Med; 2009 Jul; 169(13):1246-7; author reply 1247. PubMed ID: 19597079
    [No Abstract]   [Full Text] [Related]  

  • 16. Initiating insulin in type 2 diabetes mellitus: there's no rush.
    Cohen Y
    Isr Med Assoc J; 2004 May; 6(5):294-5. PubMed ID: 15151372
    [No Abstract]   [Full Text] [Related]  

  • 17. Trends in the quality of care for elderly people with type 2 diabetes: the need for improvements in safety and quality (the 2001 and 2007 ENTRED Surveys).
    Pornet C; Bourdel-Marchasson I; Lecomte P; Eschwège E; Romon I; Fosse S; Assogba F; Roudier C; Fagot-Campagna A;
    Diabetes Metab; 2011 Apr; 37(2):152-61. PubMed ID: 21435929
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Reduction of cardiovascular risk--a new approach in therapy of type 2 diabetes].
    Standl E
    Med Klin (Munich); 2003 Oct; 98 Suppl 1():1. PubMed ID: 14694833
    [No Abstract]   [Full Text] [Related]  

  • 19. [Prospective pioglitazone clinical trial in macrovascular events].
    Asanuma H; Kitakaze M
    Nihon Rinsho; 2012 May; 70 Suppl 3():301-8. PubMed ID: 22768537
    [No Abstract]   [Full Text] [Related]  

  • 20. [The UKPDS after one year. Diabetological realities and desiderata. United Kingdom Prospective Diabetes Study].
    Mehnert H
    Dtsch Med Wochenschr; 1999 Sep; 124(36):1021. PubMed ID: 10506838
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.